H ypertension risk is defined by interaction of both environmental and genetic factors.
H ypertension risk is defined by interaction of both environmental and genetic factors. 1 Sex has historically been regarded as a covariate, but recent studies have begun analyzing male and female populations separately and found that some genetic variants confer susceptibility to hypertension in a sex-specific manner. [2] [3] [4] [5] [6] [7] Such variants may define genetically and pathogenically distinct subgroups of men and women with hypertension and have implications for rational selection of sex-specific treatments. However, reports on female cohorts are strikingly limited and greatly restricted by population sample size, emphasizing the need for additional strategies to identify sex-specific loci.
In a previous study, 8 we used congenic mapping to identify sex-specific blood pressure (BP) loci on rat chromosome 13. This revealed a 3.7-Mb region of Brown Norway (BN) chromosome 13 (45.2-49 .0 Mb) that reduced BP by 20 mm Hg in females only, indicating the presence of female-specific BP allele(s). 8 This salt-sensitive (SS)-13 BN congenic strain (referred to as line 9) contains 83 genes in the 3.7-Mb congenic interval (chr13: 45.2-49.0 Mb), including the BP mediator Renin. 8 In the present study, we refined the line 9 congenic interval to 3 female-specific BP loci and have functionally characterized the 2 smallest quantitative trait loci (QTL; line9 BP3 and line9 BP4 ), which contained a total of 4 genes (Btg2, Prelp, Fmod, and Optc). Although no nonsynonymous coding variants were identified, we detected strain-and sex-specific differences in Btg2, Prelp, and Fmod expression. Collectively, we have identified specific candidate genes for BP that differentially impact SS hypertension in females only.
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BioSystems, Foster City, CA), as described previously. 10 Primers are listed in Table S1 in the online-only Data Supplement.
Inflammation and Fibrosis Quantitative Real-Time Polymerase Chain Reaction Array
Inflammatory and fibrotic gene expression was examined using a rat inflammatory cytokines and receptors real time-2 Profiler polymerase chain reaction Array (PARN-120ZE-4; SABiosciences, Fredrick, MD), according to the manufacturer's protocol.
Sequence Analysis
Genomic DNA sequence of BN (rn4 assembly) and SS/JrHsD/ Mcwi were accessed from the Rat Genome Database Website, as described previously. 9 Sequence analysis was performed using TargetScan, 11 Variant Effect Predictor, 12 Polyphen2, 13 TRANSFAC, and MatInspector softwares.
Statistical Analysis
Statistical analyses were performed using Sigma Plot 12.0 software. Data are presented as mean±SEM. BP data were analyzed by 1-way ANOVA on ranks followed by the Dunn post hoc test. Albuminuria data were analyzed by 1-way ANOVA followed by the Holm-Sidak post hoc test. Gene expression was analyzed by 1-way ANOVA followed by Tukey post hoc test.
Expanded Materials and Methods are provided in the online-only Data Supplement.
Results
Blood Pressure
A series of SS-13 BN congenic rat strains were phenotyped for MAP and urinary albumin excretion as depicted in the Figure. After 21 days on 8% NaCl diet, the MAP of line 9 (173±7 mm Hg; n=11), line 9C (169±6 mm Hg; n=21), line 9E (187±6 mm Hg; n=11), and line 9F (180±7 mm Hg; n=12) male rats were not significantly different from SS (Figure) . In contrast, after 21 days on 8% NaCl diet, the MAP of female rats from line 9 (149±7 mm Hg; P<0.05; n=11), line 9C (152±3; P<0.05; n=28), and line 9F (153±7 mm Hg; P<0.05; n=9) were significantly lower than line 9E (186±3 mm Hg; n=8) and SS (174±5 mm Hg; n=13; Figure) . (Figure) . However, because line 9E males were also hypertensive, it is not possible to establish whether the hypertensive BN allele(s) within the 23-kb region are sex-specific on the basis of BP alone. A protective locus also likely exists within the 2.0-Mb region (chr13: 47.0-49.0 Mb) that lowered BP in line 9C.
Renal Damage
To assess renal damage, urine was collected from SS and SS-13 BN congenic rats on 8% NaCl diet for 17 days and total urinary albumin excretion was quantified. Similar to BP, male albuminuria in lines 9 (255±49 mg), 9C (242±25 mg), 9E (343±41 mg), and 9F 224±31 mg) were not statistically different from male SS rats (198±36 mg; Figure) . Albuminuria in female lines 9 (45±12 mg; P<0.001), 9C (70±8 mg; P<0.01) and 9F (60±11 mg; P<0.01) was lower than SS (135±15 mg; Figure) , suggesting that renal protection is secondary to significantly decreased BP in females of these congenic lines. In comparison, female line 9E rats had much higher albuminuria (230±32 mg; P=0.066) compared with SS ( Figure) but was just below the threshold for statistical significance. Because line 9E and SS female rats are similarly hypertensive on 8% NaCl diet (186±3 versus 174±5 mm Hg), these data suggest that the BN allele(s) within the 23-kb region (chr13: 47,008,948-47,031,810 bp) may also modify renal damage independently of BP.
Sequence Analysis
Compared with the BN reference, a total of 5143 variants were previously identified over the entire line 9 congenic interval. 10 Further congenic mapping to narrow the protective 2.0-Mb BN interval (chr13: 47.0-49.0 Mb) in line 9C to a more manageable size will be required before a more in-depth analysis can be pursued. Therefore, we have focused our analysis specifically on the smaller line9 BP3 and line9 BP4 QTL defined by the line 9E and 9F congenic strains.
Line9 BP3
The line9 BP3 QTL is a 591-kb protective region of BN (chr13: 46,420,127-47,010,821 bp) that contains 3 genes (Optc, Prelp, and Fmod) and 264 total variants, with no coding variants and none predicted to interfere with the 3' untranslated region. Of note, 10 variants were predicted to interfere with consensus transcription factor-binding sites of the putative 5′ promoters of Optc, Prelp, and Fmod (Table S2 ).
Line9 BP4
The line9 BP4 QTL is a 23-kb hypertensive region of BN (chr13: 47,008,948-47,031,810 bp) that contains only Btg2 and 18 total variants, none of which are located in coding regions of Btg2 (Table S3 ). Of note, 9 variants were predicted to change consensus transcription-binding sites and 2 variants were located in the 3' untranslated region, but were not predicted to interfere with any miRNA-binding sites (Table S3) .
Candidate Gene Expression
The BP and albuminuria ( Figure) indicate that variant(s) modifying BP in a female-specific manner likely reside in the line9 BP3 and line9 BP4 QTLs. However, neither QTL had any predicted nonsynonymous variants within the protein-coding regions that could account for BP changes. Instead, we hypothesized that noncoding variants could impact gene expression. To test this possibility, we performed quantitative real-time polymerase chain reaction analysis of candidate gene expression (Optc, Prelp, Fmod, and Btg2) in kidneys of SS, line 9E, and line 9F congenic strains on low-salt diet (0.4% NaCl) and after 7 days on high-salt diet (8% NaCl). After 7 days of highsalt diet, BP was not significantly different between strains ( Figure S1 ), thus representing an early stage of the development of hypertension, at which point the underlying mechanisms can be assessed independently of BP differences.
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Line9 BP3
The line9 BP3 QTL significantly decreased BP in line 9F females, but not males (Figure) . Line9 BP3 contains 3 validated genes (Fmod, Prelp, and Optc) that do not have nonsynonymous changes. Optc is a class III small leucine-rich repeat protein that is largely restricted to the eye 15 and has no reported role in BP or renal function. Based on this, and the relatively low Optc expression in the kidney that did not change in females, we have deprioritized Optc on the list of candidate genes. Compared with SS, both male and female line 9F rats on low (0.4% NaCl)-and high (8% NaCl)-salt diets had significantly decreased medullary expression of Prelp (male, −81% to −87% versus SS; P<0.001 and female, −83% to −89% versus SS; P<0.001) and Fmod (male, −97% to −99% versus SS; P<0.001 and female, −96% to −97% versus SS; P<0.001; Table) . Compared with SS, cortical expression in line 9F males and females also showed similar trends to the renal medulla, except for elevated Prelp expression in the renal cortex of line 9F females on both diets (Table) .
Line9 BP4
The line9 BP4 QTL in line 9E females increased BP by 34mm Hg compared with line 9F (Figure) , indicating the presence of hypertensive BN allele(s). Only Btg2 resides in the line9 BP4 congenic interval. In males, Btg2 expression was not significantly different in any of the groups tested (Table) . In contrast, baseline Btg2 expression in renal cortex of line 9E females was 1.9±0.2-fold (P<0.05) higher than line 9F, suggesting that BN allele(s) in line9 BP4 increase baseline Btg2 expression independently of BP. After 7 days of 8% NaCl diet, Btg2 expression significantly increased 2.6±0.2-and 2.9±0.7-fold (P<0.05) in the cortex of both lines 9E and 9F, respectively (Table) , indicating that Btg2 responds to salt-challenge in females only. Similar trends were also observed in the renal medulla, but did not reach statistical significance.
Renin Expression
The renin-angiotensin system is widely implicated in sex-specific BP. [16] [17] [18] Moreover, BN allele(s) in a SS-13 BN congenic that overlaps with lines 9E and 9F were reported to restore normal renin expression/function, 10 prompting us to determine whether renin expression differed in lines 9E and 9F. After 7 days of 8% NaCl diet, renin expression was decreased 60% to 80% (P<0.05) by salt-challenge in all strains tested, but no differences between males or females of either strains were detected (Table S4 ). This indicates that sex-specific BP differences between line 9E and 9F rats are likely independent of Renin. September 2013
Tissue Remodeling Pathways
Dysfunction in the renal outer medulla has been suggested as a primary cause of SS hypertension in the SS rat, leading to renal damage and fibrosis. 19 Because Fmod, Prelp, and Btg2 have been implicated in tissue remodeling, [20] [21] [22] [23] [24] [25] we hypothesized that the differences in candidate gene expression would coincide with downstream changes in inflammatory and fibrosis pathways that mediated tissue remodeling. To test this possibility, we analyzed expression of 88 remodeling genes by quantitative real-time polymerase chain reaction array in the renal medullas of SS, line 9E, and line 9F congenic strains on low-salt diet (0.4% NaCl) and after 7 days on high-salt diet (8% NaCl).
Line9 BP3
Compared with SS, 38 of 88 genes were uniquely downregulated (−1.5 to −61.5-fold) during salt-challenge in the protected line 9F females only (Table S5 ). The downregulated pathways included metalloproteases (6 of 7), interleukins (6 of 7), and members of the transforming growth factor-β pathway (12 of 20; Table S5 ), suggesting that multiple factors in tissue remodeling are actively suppressed in the protected line 9F females. Of the 38 genes downregulated in the line 9F females, 26 were also decreased (−1.5-to −13.3-fold) in the unprotected line 9F males during salt-challenge (Table S5) .
Line9 BP4
We also tested whether tissue remodeling pathways were upregulated in the hypertensive line 9E females compared with the protected line 9F. Surprisingly, 24 of 88 genes were uniquely upregulated (1.5-5.6-fold) in line 9E females compared with line 9F females, of which only 1 was shared by the line 9E males (Table S5) . Even more strikingly, 18 of the 24 genes that were upregulated by salt-challenge in line 9E females were actively suppressed in the line 9F females (Table S5) .
Discussion
Multiple human 4, 7, 26 and rat [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] studies have identified sexspecific BP loci; however, the majority of these have failed to translate to mechanistic discoveries. Previously, we identified a 3.7-Mb QTL on rat chromosome 13 (45.2-49.0 Mb) that attenuated SS BP in female rats only. 8 Here, we identified ≥3 QTL that mediated BP in females only (Figure) . In the 2 smallest congenics (lines 9E and 9F), we reduced the total congenic intervals from 3.7 Mb to 614 kb and identified 2 BP loci (line9 BP3 and line9 BP4 ), which contained a total of 3 differentially expressed candidate genes (Fmod, Prelp, and Btg2). On the basis of these findings, Fmod, Prelp, and Btg2 are novel BP candidate genes and potential therapeutic targets for female-specific genetic hypertension.
How Does Sex Influence Genetic Hypertension?
Estrogen and the X chromosome are associated with lower BP, [16] [17] [18] but it is largely unknown how these factors interact with genetic loci. Despite this, there is clear indication that some BP loci differ between males and females 4, 7, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] and it is highly likely that several mechanisms exist. One possibility is that promoter response elements for hormone receptors (eg, estrogen or androgen receptors) or X-linked transcription factors are disrupted by genetic variants, which modifies sexspecific expression of a candidate gene that influences disease pathogenesis. For example, genetic variants frequently disrupt the estrogen response elements in the promoter of the tumor suppressor gene, BRCA1. 37 The resulting downregulation of BRCA1 protein then increases breast cancer risk. Similar to BRCA1, 37 our data suggest that Btg2 expression is likely regulated by estrogen and/or X-linked factors because changes in Btg2 expression were specific to females only (Table) . This fits with previous evidence of BTG2 promoter regulation by estrogen receptor (ER) response elements. [39] [40] [41] By sequence analysis, we also identified multiple conserved ER response elements in the rat Btg2 promoter and in close proximity to sequence variants; however, none were predicted to be disrupted by sequence variants. Several other transcription factors that were predicted to bind the Btg2 promoter (ERRα [estrogen-related receptor alpha], Gata-1/-2/-3, and Myb) also interact with ER signaling, [42] [43] [44] suggesting that estrogen could also indirectly regulate the Btg2 promoter by interacting with other transcriptional machinery. Because ER forms transcription factor complexes (eg, with ERRα, 44 Gata-1/-2/-3, 42 and Myb), 43 it is also possible that variation in binding sites of these transcription factors in the Btg2 promoter (Table S3) could influence ER-mediated Btg2 expression in the kidney. We also detected a putative binding site for the sex-determining transcription factor Sry in the Btg2 promoter (Table S3 ). However, although Sry is widely implicated in male hypertension, 18 it is Y-linked and, therefore, likely not accountable for the female-specific changes in Btg2 expression that we observed in line 9E (Table) .
Sex might also influence response to the effects of a genetic locus (ie, hypersensitivity in one gender versus the other). Our data suggest that only line 9F females are protected by low Prelp and Fmod expression (Figure) , despite these genes being strongly downregulated in both sexes (Table) . This fits with evidence that multiple mouse knockouts (eg, cyclooxygenase 2, 45 low-density lipoprotein receptor, 46 and endothelial nitric oxide synthase) 47 and the mRen2.Lewis transgenic rat model 48 show sexual dimorphism in BP and hypertension risk. Although transgenic models do not constitute a genetic locus per se, one could argue that these transgenic models demonstrate dimorphic phenotypes on the basis of sex and genotype interactions.
Candidate Genes
Line9 BP3
Compared with SS, the BN-derived allele(s) in line9 BP3 significantly decreased Fmod and Prelp expression in line 9F females (Table) , which predisposed only the line 9F females to lower BP and albuminuria (Figure) . Fmod and Prelp belong to the class II family of small leucine-rich repeat proteins, which has been previously implicated in renal damage and fibrosis. 20 Fmod is expressed in the peritubular kidney, 23 is elevated during renal fibrosis, 49 and interacts directly with the profibrotic mediator, transforming growth factor-β. 50 Prelp is also highly expressed in the kidney 50 and in other tissues, which regulates the inflammatory mediator, nuclear factor-κB. 51 In addition, both Fmod and Prelp are also implicated in complement pathway activation, 52 which has been associated with increased kidney damage. 53 Collectively, these data support that the downregulation of remodeling pathways in line 9F (Table S5 ) are likely the result of decreased expression of Fmod and Prelp (Table) .
Line9 BP4
Btg2 is the only gene residing in line9 BP4 and is elevated in female line 9E rats before salt-challenge (Table) , suggesting that elevated Btg2 expression predisposes line 9E females to hypertension (Figure) . Btg2 is highly expressed in the kidney proximal tubules, 54 but has no previously reported role in BP or renal damage. Btg2 is a transcriptional coregulator involved in cell-cycle, 41, 55 apoptosis, 55 inflammation, 24 and fibrosis. 56 In addition to regulation by ER, 24 the Btg2 promoter is also regulated by nuclear factor-κB 24 and p53 57, 58 in response to multiple inflammatory stimuli, including transforming growth factor-β 56 and tumor necrosis factor-α. 24 Collectively, these data suggest that similar Btg2-dependent mechanism(s) might influence female-specific renal inflammation and fibrosis.
Line 9 is a Compound BP QTL
The existence of both line9 BP3 and line9 BP4 demonstrates that line 9 is a compound BP QTL. Moreover, the hypertensive line9 BP3 QTL (Btg2) offsets the BP-lowering effects of the protective line9 BP4 QTL (Fmod and Prelp; Figure) , indicating that these are interdependent BP loci. However, at present it is unclear whether line9 BP3 and line9 BP4 are merely subtractive or have an epistatic relationship (ie, phenotypic manifestation of one variant is dependent on the other). 59 On the basis of the literature, 24, 50, 51, 56 it is possible that Btg2, Fmod, and Prelp could indirectly interact through common pathways (eg, transforming growth factor-β, nuclear factor-κB, and complement factor). However, epistatic interaction(s) among Btg2, Fmod, and Prelp have yet to be tested empirically.
In addition to line9 BP3 and line9 BP4 , at least one other BP QTL resides within the original line 9 congenic interval Figure) . This additional BP locus offsets the hypertensive effects of line9 BP4 , indicating the existence of potentially 3 epistatic BP loci within a 2.6-Mb interval (chr13: 46.4-49.0 Mb). Our data also suggest that the third BP locus in line 9C (chr13: 47.0-49.0 Mb) is unique to females only. We recently published that ≥2 other BP loci reside in the line 9 congenic interval using male rats only. 60 One BN locus (chr13: 47.2-49.0 Mb; referred to as line9 BP2 ) was hypertensive and the other BN locus, containing Renin (chr13: 46.1-47.2; referred to as line9 BP1 ), lowered BP in male rats. 60 At present, it seems that the male BP QTL identified previously 60 and the female BP QTL identified here (Figure) are likely not shared. Although the protective line9 BP1 (male) and line9 BP3 (female) QTL overlapped, the line 9E males were not protective, suggesting that protective BP loci in this region are sex-specific. Likewise, the overlapping hypertensive line9 BP2 (male) and protective line9 BP4 (female) QTL had opposite phenotypes, indicating that BP loci in these QTL are very likely not shared. Further congenic mapping, ZFN-mutagenesis, and molecular analysis will be required to (1) narrow the protective BP allele(s) in line 9C (chr13: 47.0-49.0 Mb) and (2) test whether epistasis or purely additive effects regulate overall hypertension risk for females in the line 9 congenic region.
Perspectives
The observed sex differences in BP regulation are longstanding, 18 but the mechanism(s) specific to genetic hypertension in females are largely unresolved. Despite this, the majority of BP studies have focused primarily on male hypertension.
Here, we identified a 614-kb region on rat chromosome 13 that contains 2 female-specific BP loci. Within these loci, we identified 3 differentially expressed candidate genes (Btg2, Fmod, and Prelp) that are specific to female BP and offer potential therapeutic targets for treating female hypertension. Future studies will be needed to test the functional roles of Btg2, Fmod, and Prelp in the kidney and potentially other tissues involved in the development of hypertension. Figure S1 . Time course of the development of hypertension in the SS, line 9, line 9E, and line 9F rats fed low salt (0.4% NaCl) or high salt (8% NaCl) diets for 21 days (group sizes are given in Figure 1 ). Mean arterial pressure (MAP) was recorded by radiotelemetry in male (A) and female (B) rats, as described in the methods. MAP at 21 day of high salt diet is also reported in Figure 1 . Data are presented as MAP ± SEM. P-values are determined by a 1-way ANOVA followed by a Holm-Sidak post hoc test. For (B), *P<0.05, line 9 vs. SS; † P<0.05, line 9 and line 9F vs. line 9E and SS; ‡ P<0.001, line 9 and line 9F vs. line 9E and SS.
